When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel

201366 citationsJournal Article

Authors

Valérie Pittet · Institute of Social and Preventive Medicine

Florian Froehlich · Hospital Base

Michel H. Maillard · University of Lausanne

Christian Mottet · University of Lausanne

Jean‐Jacques Gonvers · University of Lausanne

Christian Felley · Clinique de La Source

John-Paul Vader

Abstract

A multidisciplinary European expert panel proposed for the first time treatment stopping rules for patients in clinical and/or endoscopic remission, with normal CRP and fecal calprotectin levels.

Topics & Keywords

Inflammatory Bowel Disease Microscopic Colitis Autoimmune and Inflammatory Disorders

Publication Details

Published in: Journal of Crohn s and Colitis

Volume 7, Issue 10, pp. 820-826

DOI: 10.1016/j.crohns.2013.04.013

Field-Weighted Citation Impact: 8.35

Command Palette

When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel

Authors

Abstract

Topics & Keywords

Publication Details